1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
(
- Contribution to journal › Article
- 2011
-
Mark
Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.
(
- Contribution to journal › Article
- 2007
-
Mark
Long-term follow-up of the hepatitis CHENCORE cohort: response to therapy and occurrence of liver-related complications
(
- Contribution to journal › Article
- 2005
-
Mark
Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response
(
- Contribution to journal › Article
- 2004
-
Mark
Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance
(
- Contribution to journal › Article
- 1999
-
Mark
Hepatitis G virus infections in Iceland
(
- Contribution to journal › Article
- 1998
-
Mark
Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence
(
- Contribution to journal › Article